黑龙江医学
黑龍江醫學
흑룡강의학
HEILONGJIANG MEDICAL JOURNAL
2015年
5期
559-560
,共2页
质子泵抑制剂%骨质疏松%骨密度%骨源性碱性磷酸酶
質子泵抑製劑%骨質疏鬆%骨密度%骨源性堿性燐痠酶
질자빙억제제%골질소송%골밀도%골원성감성린산매
Proton pump inhibitor%Osteoporosis%Bone mineral density%Bone alkaline phosphatase
目的:研究长期应用质子泵抑制剂是否可影响钙的吸收,从而加重或导致骨质疏松。方法选取在我科治疗的50例长期(大于3个月)口服质子泵抑制剂患者为调查对象,分别于服药前、服药1年后、服药2年后测定其骨密度及骨源性碱性磷酸酶活性。结果所调查患者服药2年后骨密度明显低于服药前及服药1年后( P<0.05),骨源性碱性磷酸酶活性明显高于服药前及服药1年后(P<0.05),差异有统计学意义。服药1年后与服药前骨密度及骨源性碱性磷酸酶活性测定比较,差异无统计学意义( P>0.05)。结论长时间服用质子泵抑制剂可加重或导致骨质疏松。
目的:研究長期應用質子泵抑製劑是否可影響鈣的吸收,從而加重或導緻骨質疏鬆。方法選取在我科治療的50例長期(大于3箇月)口服質子泵抑製劑患者為調查對象,分彆于服藥前、服藥1年後、服藥2年後測定其骨密度及骨源性堿性燐痠酶活性。結果所調查患者服藥2年後骨密度明顯低于服藥前及服藥1年後( P<0.05),骨源性堿性燐痠酶活性明顯高于服藥前及服藥1年後(P<0.05),差異有統計學意義。服藥1年後與服藥前骨密度及骨源性堿性燐痠酶活性測定比較,差異無統計學意義( P>0.05)。結論長時間服用質子泵抑製劑可加重或導緻骨質疏鬆。
목적:연구장기응용질자빙억제제시부가영향개적흡수,종이가중혹도치골질소송。방법선취재아과치료적50례장기(대우3개월)구복질자빙억제제환자위조사대상,분별우복약전、복약1년후、복약2년후측정기골밀도급골원성감성린산매활성。결과소조사환자복약2년후골밀도명현저우복약전급복약1년후( P<0.05),골원성감성린산매활성명현고우복약전급복약1년후(P<0.05),차이유통계학의의。복약1년후여복약전골밀도급골원성감성린산매활성측정비교,차이무통계학의의( P>0.05)。결론장시간복용질자빙억제제가가중혹도치골질소송。
Objective To study whether long-term proton pump inhibitors can affect the absorption of calcium to cause or aggravate osteoporosis.Methods Selecting 50 patients who took proton pump inhibitors ( PPIs) for long-term ( more than 3 months) as the experi-mental group, and determining bone density and bone alkaline phosphatase before treatment, after 1 year and 2 years respectively.Results After 2 years,bone density was significantly lower than that before treatment and after 1 year (P<0.05).Bone alkaline phosphatase was significantly higher than that before treatment and after 1 year ( P<0.05 ) .The difference was statistically significant.The comparison of bone mineral density and bone alkaline phosphatase had no significant difference between before treatment and after 1 year ( P >0.05). Conclusion Long time taking PPI can ause or aggravate osteoporosis.